Literature DB >> 10998611

Metabolic accommodation of young children to treadmill walking.

W Tseh1, J L Caputo, I S Craig, D J Keefer, P E Martin, D W Morgan.   

Abstract

Few data exist concerning the reproducibility of stable oxygen uptake (VO(2)) values during level treadmill walking in young able-bodied children. To address this issue, 41 able-bodied 6-year-olds (19 boys, 22 girls, X height=117.2+/-4.7 cm, X body mass=21.8+/-2.5 kg) were tested on two occasions. In session 1, subjects were familiarized with the laboratory environment and performed 5 min of level treadmill walking at 1.34 m s(-1). During session 2, each child completed 30 min (three 10-min trials) of level treadmill walking at 1.34 m s(-1). For each 10-min trial, mean VO(2) was determined by averaging VO(2) values obtained from analysis of two 2-min expired gas samples. While the mean VO(2) for trial 1 was higher than values recorded for trials 2 and 3, effect sizes corresponding to these differences were low (</=0.16). Average within subject coefficient of variation and intraclass reliability coefficient values for VO(2) across the three walking trials were 2. 0+/-1.5% and 0.96, respectively. Viewed collectively, these results suggests that among young able-bodied children, acceptably and reproducible stable VO(2) values during level treadmill walking can be obtained within 10 min if data collection is preceded by exposure to testing procedures and a brief period of treadmill walking practice.

Entities:  

Mesh:

Year:  2000        PMID: 10998611     DOI: 10.1016/s0966-6362(00)00063-1

Source DB:  PubMed          Journal:  Gait Posture        ISSN: 0966-6362            Impact factor:   2.840


  1 in total

1.  Longitudinal stratification of gait economy in young boys and girls: the locomotion energy and growth study.

Authors:  Don W Morgan; Wayland Tseh; Jennifer L Caputo; Daniel J Keefer; Ian S Craig; Kelly B Griffith; Mary Beth Akins; Gareth E Griffith; Gary S Krahenbuhl; Philip E Martin
Journal:  Eur J Appl Physiol       Date:  2003-09-18       Impact factor: 3.078

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.